Physic Ventures Portfolio

Physic Ventures is systematically assembling a portfolio of consumer-focused, science-based companies in the emergent health and sustainable living marketplace. Our portfolio represents the goals and focus of our fund with investments in three focus areas: enabling technologies, branded consumer products, and innovative distribution channels.

For information about job openings within our portfolio of companies, click here.

Chromatin's patented mini-chromosome technologies enable the development of new seed products and the delivery of multiple genetic traits.  Consumers, growers, seed companies, and processors will derive greater value from crop plants through the application of Chromatin's technologies.  More efficient and faster product development, greater product differentiation, and creation of novel products are among the benefits Chromatin's technologies deliver to these users.

Learn more

Elixir Pharmaceuticals, a Cambridge, MA-based biopharmaceutical company focuses on developing and commercializing drugs to treat and prevent metabolic disease and age-related diseases, ultimately extending the quality and length of human life.

Learn more
EnergyHub is the consumer face of the Smart Grid, helping home owners reduce energy consumption and save money. EnergyHub produces smart, simple, and cost-effective energy management tools that strengthen the relationship between consumers and utilities and solve today's energy problems. Learn more

GoodGuide is a scientifically-based, consumer friendly guide to the health, environmental and social impacts of products and companies. The platform entails an integrated online and mobile IT solution providing consumers with the most comprehensive, credible, and actionable information available on the performance of products and companies. The company serves as an aggregator of the select information from government, non-profit, and private sector data sources, which are delivered to consumers wherever and whenever they need it - including a mobile application for iPhone.

Learn more

HaloSource® health science technologies focus on antimicrobial enhancing solutions that reliably and effectively kill germs.  For partners that want competitive differentiation through unique proprietary technologies, HaloSource provides reliable, tested and proven solutions in the product categories of safe water, infection control and wound healing.

Learn more

Impinj, Inc. is a fabless semiconductor company whose patented Self-Adaptive Silicon® technology enables its two synergistic business lines:  high performance RFID products and innovative semiconductor intellectual property. As a leading contributor to the RFID standards for high-volume supply-chain applications worldwide, Impinj leverages its technical expertise and industry partnerships to deliver the GrandPrix™ solution of tag, reader, software and system integration to offer RFID that just works™.  Impinj's innovative intellectual property products, core to the company's RFID tags, are licensed to leading semiconductor companies worldwide, allowing them to integrate crucial nonvolatile memory (NVM) alongside analog and digital functionality on a single chip.  Impinj's IP products include the popular AEON® family of rewriteable NVM products.

Learn more
Merrimack Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of novel treatments for cancer and autoimmune disease. Its first two oncology pipeline candidates, MM-121 and MM-111 are currently in Phase 1 clinical development. The Company's proprietary Network Biology discovery platform, developed with the help of leading scientists from MIT and Harvard, enables the high-throughput profiling of protein networks as a basis for improved validation, lead identification and speed in the development of innovative, effective and well tolerated therapeutics. Learn more

Novomer is a materials company pioneering the manufacture of novel materials from simple feedstocks. The Company's catalyst technology enables the production of polymers and plastics from renewable feedstocks, such as carbon dioxide and carbon monoxide.

Learn more

On-Q-ity is a next generation diagnostics company focused on transforming cancer treatment and improving treatment outcomes for cancer patients. The company is developing innovative diagnostics to identify the unique characteristics of an individual's cancer, predicting the response to therapies, and monitoring the progress of treatment. It achieves this using DNA repair tumor biomarkers to predict the right drug and circulating tumor cells (CTCs) to follow cancer progression.

Learn more

Pharmaca operates a chain of integrative pharmacies that combine prescription drug and OTC products with natural, complementary and personal body care products. The Company owns and operates 23 pharmacies.

Learn more

Surface Logix is a drug development company using its expertise in biophysical chemistry to create new small molecule drugs with significantly improved pharmacokinetic (PK) and pharmacodynamic (PD) properties compared with class leaders.  By using its proprietary chemistry platform — the Pharmacomer™ Technology Platform –Surface Logix creates New Chemical Entities that respond dynamically to the various physiological microenvironments in the human body.  By enhancing molecular functionality, Surface Logix is able to solve PK and PD problems not addressable with traditional medicinal chemistry practices.

Learn more

Purchased in 2008 by Adidas Group, Textronics™ is a pioneer in the field of textile electronics.  The convergence of high-tech fiber science with electronics and optics is at an early stage. However it has the potential to revolutionize fabrics from clothing to industrial textiles and significantly impact other textile sectors in the next decade.  Textronics has technology streams under development that will enable energy-active fabric systems to deliver new kinds of functional benefits.  Possibilities include fabrics that warm, illuminate, conduct, sense, and respond to various stimuli.  These benefits will be most immediately relevant to specialist applications in medicine, sports, communications, and personal security, among others, but will ultimately have broad consumer relevance.

Learn more